Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Qingzhuang Liang"'
Autor:
Dong Chen, Xi Su, Lizhang Zhu, Hao Jia, Bin Han, Haibo Chen, Qingzhuang Liang, Chenchen Hu, Hao Yang, Lisa Liu, Peng Li, Wei Wei, Yongsheng Zhao
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-18 (2023)
Abstract Backgrounds Papillary thyroid cancer (PTC), which is often driven by acquired somatic mutations in BRAF genes, is the most common pathologic type of thyroid cancer. PTC has an excellent prognosis after treatment with conventional therapies s
Externí odkaz:
https://doaj.org/article/da022887d1a44ac394e7016c8e241214
Autor:
Hao Yang, Qingzhuang Liang, Jian Zhang, Jinkun Liu, Hao Wei, Haibo Chen, Wei Wei, Dong Chen, Yongsheng Zhao
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Papillary thyroid cancer (PTC) is a common malignancy of the endocrine system, and its morbidity and mortality are increasing year by year. Traditional two-dimensional culture of cell lines lacks tissue structure and is difficult to reflect the heter
Externí odkaz:
https://doaj.org/article/27affe6c8c824d94abecf1e07bb934b3
Autor:
Xi Su, Peng Li, Bin Han, Hao Jia, Qingzhuang Liang, Haichao Wang, Mengwei Gu, Jiaxuan Cai, Shaolei Li, Yaqi Zhou, Xin Yi, Wei Wei
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-12 (2021)
Abstract Background BRAFV600E mutation is the most common mutation in thyroid cancer. It strongly activates MAPK/ERK pathway and indicates an invasive subtype of thyroid cancer. PLX4032 is a selective oral inhibitor of the BRAFV600 kinase although wi
Externí odkaz:
https://doaj.org/article/28f8b70efe1143048768c297848254fe
Autor:
Mengwei Gu, Yaqi Zhou, Peng Li, Shaolei Li, Xi Su, Bin Han, Wei Wei, Haichao Wang, Qingzhuang Liang, Xin Yi, Jiaxuan Cai, Hao Jia
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-12 (2021)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Background BRAFV600E mutation is the most common mutation in thyroid cancer. It strongly activates MAPK/ERK pathway and indicates an invasive subtype of thyroid cancer. PLX4032 is a selective oral inhibitor of the BRAFV600 kinase although with limite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdcb30707e96a98ceac9212092f921b7
https://doaj.org/article/28f8b70efe1143048768c297848254fe
https://doaj.org/article/28f8b70efe1143048768c297848254fe
Autor:
Su, Xi, Li, Peng, Han, Bin, Jia, Hao, Qingzhuang Liang, Haichao Wang, Mengwei Gu, Jiaxuan Cai, Shaolei Li, Yaqi Zhou, Yi, Xin, Wei, Wei
Additional file 1: Supplemental Fig. 1. The representative views of EdU staining of (a) 8505C, (b) BCPAP and (c) 8305C cell lines after a 24-h’s treatment with 6 μM PLX4032 or 0.25 mM vitamin C, individually or in combination. Scale bars: 100 μm.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd095178246143a2bd26412d562ea147
Autor:
Su, Xi, Li, Peng, Han, Bin, Jia, Hao, Qingzhuang Liang, Haichao Wang, Mengwei Gu, Jiaxuan Cai, Shaolei Li, Yaqi Zhou, Yi, Xin, Wei, Wei
Additional file 4. Ethical approval document of this research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1471ea628ef7973a082d520635139338
Autor:
Su, Xi, Li, Peng, Han, Bin, Jia, Hao, Qingzhuang Liang, Haichao Wang, Mengwei Gu, Jiaxuan Cai, Shaolei Li, Yaqi Zhou, Yi, Xin, Wei, Wei
Additional file 3: Supplemental Fig. 3. The body weight of the nude mice was measured every other day after drug administration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51330e649623b139d4d531110e68b41f
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 37(10)
The aim of this study was to assess the impact of radiotherapy on patients with postoperative residual or recurrent papillary thyroid cancer (PTC).We retrospectively reviewed the medical records of 34 patients with PTC, who underwent surgery and radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::633a78cf47154975b240e22f562f8b73
https://pubmed.ncbi.nlm.nih.gov/26813599
https://pubmed.ncbi.nlm.nih.gov/26813599
Publikováno v:
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery. 50(6)
To assess the efficacy of radioactive iodine (RAI) for the treatment of residual papillary thyroid cancer (PTC) after surgery.A total of 20 patients diagnosed with PTC and underwent 2-6 courses of RAI therapy for residual PTC after surgery in other h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::759d169625d3a65f9cc6bd48290eb664
https://pubmed.ncbi.nlm.nih.gov/26695803
https://pubmed.ncbi.nlm.nih.gov/26695803
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 37(2)
To analyze the factors affecting prognosis of the carcinoma arising from nasal and sinonasal inverted papilloma.The clinicopathological data of sixty-two patients treated in our hospital from January 1974 to February 2012 were retrospectively analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c130c742a9a602a1b37b9e988628ba1b
https://pubmed.ncbi.nlm.nih.gov/25975691
https://pubmed.ncbi.nlm.nih.gov/25975691